About: Vonoprazan/amoxicillin

An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Vonoprazan/amoxicillin, sold under the brand name Voquezna Dual Pak among others, is a co-packaged medication used for the treatment of Helicobacter pylori (H. pylori) infection. It contains vonoprazan (as the fumarate), a potassium-competitive acid blocker and amoxicillin, a beta-lactam antibiotic. The co-packaged medication was approved for medical use in the United States in May 2022.

Property	Value
dbo:abstract	Vonoprazan/amoxicillin, sold under the brand name Voquezna Dual Pak among others, is a co-packaged medication used for the treatment of Helicobacter pylori (H. pylori) infection. It contains vonoprazan (as the fumarate), a potassium-competitive acid blocker and amoxicillin, a beta-lactam antibiotic. The co-packaged medication was approved for medical use in the United States in May 2022. (en)
dbo:alternativeName	Voquezna Dual Pak (en)
dbo:wikiPageExternalLink	https://druginfo.nlm.nih.gov/drugportal/name/vonoprazan https://druginfo.nlm.nih.gov/drugportal/name/amoxicillin
dbo:wikiPageID	70744081 (xsd:integer)
dbo:wikiPageLength	7869 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1096238771 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Amoxicillin dbc:Combination_drugs dbc:Drugs_acting_on_the_gastrointestinal_system_and_metabolism dbc:Proton-pump_inhibitors dbr:Vonoprazan dbr:Potassium-competitive_acid_blocker dbr:Indicated dbr:Beta-lactam_antibiotic
dbp:atcPrefix	None (en)
dbp:class	dbr:Potassium-competitive_acid_blocker dbr:Beta-lactam_antibiotic
dbp:component	Amoxicillin (en) Vonoprazan (en)
dbp:dailymedid	Voquezna (en)
dbp:legalUs	Rx-only (en)
dbp:tradename	Voquezna Dual Pak (en)
dbp:type	combo (en)
dbp:wikiPageUsesTemplate	dbt:Gastrointestinal-drug-stub dbt:Cite_web dbt:Infobox_drug dbt:Portal_bar dbt:Reflist dbt:Short_description dbt:Use_American_English dbt:Use_dmy_dates dbt:Drugs_for_peptic_ulcer_and_GORD
dct:subject	dbc:Combination_drugs dbc:Drugs_acting_on_the_gastrointestinal_system_and_metabolism dbc:Proton-pump_inhibitors
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:CombinationDrug dbo:Drug
rdfs:comment	Vonoprazan/amoxicillin, sold under the brand name Voquezna Dual Pak among others, is a co-packaged medication used for the treatment of Helicobacter pylori (H. pylori) infection. It contains vonoprazan (as the fumarate), a potassium-competitive acid blocker and amoxicillin, a beta-lactam antibiotic. The co-packaged medication was approved for medical use in the United States in May 2022. (en)
rdfs:label	Vonoprazan/amoxicillin (en)
owl:sameAs	wikidata:Vonoprazan/amoxicillin dbpedia-fa:Vonoprazan/amoxicillin https://global.dbpedia.org/id/GUYuP
prov:wasDerivedFrom	wikipedia-en:Vonoprazan/amoxicillin?oldid=1096238771&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Vonoprazan/amoxicillin
is dbo:wikiPageRedirects of	dbr:Voquezna_Dual_Pak
is dbo:wikiPageWikiLink of	dbr:Vonoprazan dbr:Voquezna_Dual_Pak
is foaf:primaryTopic of	wikipedia-en:Vonoprazan/amoxicillin